TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 96 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $290,000 | -7.9% | 42,362 | -4.0% | 0.00% | 0.0% |
| Q2 2017 | $315,000 | -43.4% | 44,122 | -27.2% | 0.00% | -50.0% |
| Q1 2017 | $557,000 | +468.4% | 60,622 | +148.2% | 0.00% | – |
| Q4 2016 | $98,000 | +6.5% | 24,422 | +1.3% | 0.00% | – |
| Q3 2016 | $92,000 | -11.5% | 24,109 | 0.0% | 0.00% | – |
| Q2 2016 | $104,000 | -7.1% | 24,109 | 0.0% | 0.00% | – |
| Q1 2016 | $112,000 | -53.7% | 24,109 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $242,000 | +38.3% | 24,109 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $175,000 | -91.1% | 23,408 | -43.6% | 0.00% | -87.5% |
| Q2 2015 | $1,968,000 | +162.1% | 41,478 | +102.5% | 0.01% | +166.7% |
| Q1 2015 | $751,000 | -3.8% | 20,484 | +4.2% | 0.00% | 0.0% |
| Q4 2014 | $781,000 | +132.4% | 19,667 | +16.8% | 0.00% | +200.0% |
| Q3 2014 | $336,000 | +48.7% | 16,842 | +0.5% | 0.00% | 0.0% |
| Q2 2014 | $226,000 | +93.2% | 16,761 | +56.5% | 0.00% | 0.0% |
| Q1 2014 | $117,000 | -19.3% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $145,000 | +39.4% | 10,709 | +17.0% | 0.00% | – |
| Q3 2013 | $104,000 | +316.0% | 9,156 | +153.2% | 0.00% | – |
| Q2 2013 | $25,000 | – | 3,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |